Skip to content

This is a Study to Verify if Marrow Venting Procedure Can Improve Meniscal Suture Healing

Biological Augmentation Of Meniscal Repair With Marrow Venting: A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05053646
Enrollment
80
Registered
2021-09-22
Start date
2021-12-29
Completion date
2030-10-01
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meniscal Tear

Brief summary

Meniscal suture represents the current surgical practice, and marrow venting is a low risk procedure. Bone venting may be able to improve the outcome of meniscal repair, allowing the patient a better recovery.

Detailed description

Meniscal tears are one of the most common lesions of the knee and are a risk factor for the development of knee osteoarthritis. A meniscal tear commonly causes knee pain, stiffness, loss of function and sometimes catching or locking of the knee, affecting patients' ability to participate in their everyday activities. In case of ineffective conservative management, meniscal tears are treated with meniscectomy (partial or total) or meniscal repair, with the latter considered, when possible, the optimal choice. Meniscal repair consists of a suture that juxtaposes the flaps of the injured meniscus to facilitate the healing of the tear. Unfortunately, meniscal healing capability is limited. A higher rate of meniscal tears healing has been documented in patients treated simultaneously with a meniscal repair and anterior cruciate ligament reconstruction. A surgical augmentation technique performing micro-fractures on the medial aspect of the lateral femoral condyle during meniscal repair surgery has been developed to mimic the beneficial effect of anterior cruciate ligament reconstruction on the joint environment. This technique has been successfully tested in preclinical studies, in human cohort studies and, recently, in a randomized control trial. However, these randomised controlled trials present some methodological weaknesses, such as a low number of included patients, and included only full-thickness vertical longitudinal tears in the red-red zone, the meniscal tears with the highest healing potential. The effect of additional micro-fractures on the healing capacity of meniscal tears involving the red-white zone has never been tested.

Interventions

The meniscus is trimmed with an arthroscopic punch followed by an electric shaver to expose the margins of the tear and remove damaged tissue. Vertical sutures are made using TRUESPAN™ Meniscal Repair System (DePuy Synthes) to approximate both the femoral and tibial surfaces of the torn meniscus.

PROCEDUREMarrow venting procedure

After meniscal repair, a bone marrow venting procedure will be performed: a 45° micro-fracture awl is repeatedly penetrated through the bone of the intercondylar notch at the PCL origin until marrow elements are seen to enter the joint.

Sponsors

Christian Candrian
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
16 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Arthroscopic confirmed suturable meniscal tears, * Monolateral meniscal tears, * 18-45 years, * BMI\>18,5 and \<35 kg/m2, * Ability to give informed consent by signature.

Exclusion criteria

* Bilateral meniscal tears requiring treatment, * Associated ligament lesions requiring treatment, * Associated cartilage lesions (Outerbridge \> 2), * Knee axis deformities requiring correction * Generalized ligamentous laxity, * Radiographic knee ostheoarthritis, * Other reasons for knee pain, * Pregnant or lactating women, * Serious systemic diseases such as cardiac, hepatic or renal failure, rheumatic diseases, non-compensated diabetic, psychological illnesses, central or peripheral neurological diseases, and autoimmune diseases, * Enrolled in another ongoing clinical trial.

Design outcomes

Primary

MeasureTime frameDescription
subjective International Knee Documentation Committee (IKDC) score2 yearsevaluated subjective IKDC score 2-years after intervention in two groups

Secondary

MeasureTime frameDescription
Objective International Knee Documentation Committee (IKDC)(pre-operative, 6 weeks, 3 months, 6 months, 1 year, 2 years, 5 years)Objective IKDC - International Knee Documentation Committee (pre-operative, 6 weeks, 3 months, 6 months, 1 year, 2 years, 5 years)
Lysholm score (pre-operative, 6 weeks, 3 months, 6 months, 1 year, 2 years, 5 years)(pre-operative, 6 weeks, 3 months, 6 months, 1 year, 2 years, 5 years)Lysholm score (pre-operative, 6 weeks, 3 months, 6 months, 1 year, 2 years, 5 years)
Knee Injury and Osteoarthritis Outcome Score - KOOS(pre-operative, 6 weeks, 3 months, 6 months, 1 year, 2 years, 5 years)Knee Injury and Osteoarthritis Outcome Score - KOOS (pre-operative, 6 weeks, 3 months, 6 months, 1 year, 2 years, 5 years)
Pain 0-10 Numerical Rating Scale (NRS)(pre-operative, 6 weeks, 3 months, 6 months, 1 year, 2 years, 5 years)Pain 0-10 numerical rating scale - NRS (pre-operative, 6 weeks, 3 months, 6 months, 1 year, 2 years, 5 years)
Function 0-10 Numerical Rating Scale (NRS)(pre-operative, 6 weeks, 3 months, 6 months, 1 year, 2 years, 5 years)Function 0-10 numerical rating scale - NRS (pre-operative, 6 weeks, 3 months, 6 months, 1 year, 2 years, 5 years)
Tegner score(prior to the injury (e.g. referred to the day before), pre-operative, 6 weeks, 3 months, 6 months, 1 year, 2 years, 5 years)Tegner score (prior to the injury (e.g. referred to the day before), pre-operative, 6 weeks, 3 months, 6 months, 1 year, 2 years, 5 years)
Healing rate1 yearHealing rate (MRI at 1 year)
Treatment related adverse events5 yearsTreatment related adverse events: overall, intra-operative, short- (\<3 months), mid- (3 months, 2 years), long-term (\>2 years) adverse events
Function curves during the first 6 weeks.6 weeksFunction curves during the first 6 weeks.
Pain curves during the first 6 weeks.6 weeksPain curves during the first 6 weeks as retrieved by the values produced with the EOC EMApp.
Radiographic progression of knee osteoarthritis5 yearsRadiographic progression of knee osteoarthritis (x-ray at 5 years)

Countries

Switzerland

Contacts

CONTACTChristian R Candrian, MD
RicercaOrtopedia.ORL@eoc.ch+41918117029
CONTACTGabriela Induni-Lang
Gabriela.Induni-Lang@eoc.ch+41918117029
PRINCIPAL_INVESTIGATORChristian Candrian, MD

Ente Ospedaliero Cantonale, Bellinzona

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026